| UniProt ID | MIEN1_HUMAN | |
|---|---|---|
| UniProt AC | Q9BRT3 | |
| Protein Name | Migration and invasion enhancer 1 | |
| Gene Name | MIEN1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 115 | |
| Subcellular Localization |
Cytoplasm, cytosol. Cell membrane Lipid-anchor Cytoplasmic side. Concentrates at the leading edge of migrating cells. Localizes outside membrane raft regions. |
|
| Protein Description | Increases cell migration by inducing filopodia formation at the leading edge of migrating cells. Plays a role in regulation of apoptosis, possibly through control of CASP3. May be involved in a redox-related process.. | |
| Protein Sequence | MSGEPGQTSVAPPPEEVEPGSGVRIVVEYCEPCGFEATYLELASAVKEQYPGIEIESRLGGTGAFEIEINGQLVFSKLENGGFPYEKDLIEAIRRASNGETLEKITNSRPPCVIL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSGEPGQTS ------CCCCCCCCC | 52.44 | 22814378 | |
| 2 | Phosphorylation | ------MSGEPGQTS ------CCCCCCCCC | 52.44 | 24505115 | |
| 39 | Phosphorylation | PCGFEATYLELASAV CCCCCHHHHHHHHHH | 12.77 | - | |
| 50 | Phosphorylation | ASAVKEQYPGIEIES HHHHHHHCCCCEEEE | 12.43 | - | |
| 85 | Phosphorylation | LENGGFPYEKDLIEA CCCCCCCCHHHHHHH | 33.09 | 28102081 | |
| 87 | Ubiquitination | NGGFPYEKDLIEAIR CCCCCCHHHHHHHHH | 52.57 | - | |
| 97 | Phosphorylation | IEAIRRASNGETLEK HHHHHHHHCCCHHHH | 43.48 | 28102081 | |
| 101 | Phosphorylation | RRASNGETLEKITNS HHHHCCCHHHHHHCC | 41.43 | 28102081 | |
| 112 | Geranylgeranylation | ITNSRPPCVIL---- HHCCCCCEEEC---- | 3.09 | 19503095 | |
| 112 | Geranylgeranylation | ITNSRPPCVIL---- HHCCCCCEEEC---- | 3.09 | 19503095 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MIEN1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MIEN1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MIEN1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of MIEN1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Prenylation | |
| Reference | PubMed |
| "Prenylated c17orf37 induces filopodia formation to promote cellmigration and metastasis."; Dasgupta S., Cushman I., Kpetemey M., Casey P.J., Vishwanatha J.K.; J. Biol. Chem. 286:25935-25946(2011). Cited for: FUNCTION, SUBCELLULAR LOCATION, ISOPRENYLATION AT CYS-112, ANDMUTAGENESIS OF CYS-112 AND 112-CYS--LEU-115. | |
| "Novel gene C17orf37 in 17q12 amplicon promotes migration and invasionof prostate cancer cells."; Dasgupta S., Wasson L.M., Rauniyar N., Prokai L., Borejdo J.,Vishwanatha J.K.; Oncogene 28:2860-2872(2009). Cited for: FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND PROBABLEISOPRENYLATION AT CYS-112. | |
| "C35 (C17orf37) is a novel tumor biomarker abundantly expressed inbreast cancer."; Evans E.E., Henn A.D., Jonason A., Paris M.J., Schiffhauer L.M.,Borrello M.A., Smith E.S., Sahasrabudhe D.M., Zauderer M.; Mol. Cancer Ther. 5:2919-2930(2006). Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION,AND PROBABLE ISOPRENYLATION. | |